NCNaweed Iffat Chowdhury

Naweed Iffat Chowdhury

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Naweed Iffat Chowdhury has a total of 128 co-authors. Here are the top co-authors by number of shared publications:

  • Ping Li

    Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232

    12 shared publications
  • Rakesh K. Chandra

    Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University School of Medicine, Nashville, TN

    11 shared publications
  • Justin H. Turner

    Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tenn

    9 shared publications
  • Justin H. Turner

    Department of Otolaryngology-Head and Neck Surgery, University of Alabama Marnix E. Heersink School of Medicine, Birmingham, AL 35294

    5 shared publications
  • Rakesh K. Chandra

    Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232

    5 shared publications
  • Timothy L. Smith

    Department of Otolaryngology – Head and Neck Surgery Oregon Health & Science University Portland Oregon USA

    5 shared publications

Latest Publications

  • Open Access

    Establishing the PM2.5-associated inflammatory endotype of chronic rhinosinusitis

    by Daniel H. Lofgren, Christina Dorismond, Rory J. Lubner, Katherine N. Cahill, Justin H. Turner, Rakesh K. Chandra, Mason R. Krysinski, Ping Li, Naweed I. Chowdhury


  • Open Access

    The Impact of Chronic Particulate Matter Exposure on Quality‐of‐Life Outcomes After Endoscopic Sinus Surgery

    by Chandler Rygalski, Nanda Nayak, Christina Dorismond, Rory Lubner, Daniel Lofgren, Ping Li, Katherine N. Cahill, Mason Krysinski, Rakesh Chandra, Justin Turner, et al.


  • Open Access

    Dupilumab Initiation for Surgically Refractory Chronic Rhinosinusitis With Nasal Polyps Is Associated With Differential Expression of CLC and Activation of Eicosanoid Pathways

    by Christina Dorismond, Rory J. Lubner, Daniel H. Lofgren, Chandler J. Rygalski, Ping Li, Katherine N. Cahill, Suman R. Das, Mason R. Krysinski, Rakesh K. Chandra, Justin H. Turner, et al.

    Key Points: An untargeted transcriptomic analysis provided exploratory insight into key genes and pathways that can be used to help identify patients at risk for surgically refractory chronic rhinosinusitis with nasal polyps (CRSwNP). The Charcot–Leyden crystal gene, periostin and osteopontin‐associated pathways, eicosanoid synthesis pathway, and prostaglandin/leukotriene metabolism pathway, among others, are associated with dupilumab prescription for surgically refractory chronic rhinosinusitis and may support early stratification of disease severity in CRSwNP patients.


  • Open Access

    Long‐Term Particulate Matter Exposure May Increase Risk of Chronic Rhinosinusitis WIth Nasal Polyposis: Results From an Exposure‐Matched Study

    by Rory J. Lubner, Mason Krysinski, Ping Li, Rakesh K. Chandra, Justin H. Turner, Naweed I. Chowdhury

    Background: Particulate matter ⩽2.5 µm in diameter (PM2.5) and its role in chronic rhinosinusitis (CRS) pathogenesis have gained heightened attention. We previously demonstrated that PM2.5 exposure may bias the nasal mucosa in CRS toward a Type 2 inflammatory pathway. However, there are limited data comparing cytokine changes in CRS sinonasal tissue to non‐CRS patients as it relates to PM2.5 exposure. We hypothesized that long‐term exposure preferentially increases the risk of manifesting CRS with nasal polyposis (CRSwNP).Methods: We performed a retrospective analysis of 376 patients (308 CRS, 68 controls) who underwent endoscopic sinus or skull base surgery. A spatiotemporal machine‐learning model estimated daily PM2.5 levels for 1 year prior to each patient's surgery date. Cytokines were quantified using a multiplex flow cytometric bead assay and compared to estimated PM2.5 exposure using Spearman correlation and multivariate regression. Patients with high and low 12‐month PM2.5 exposures were matched across age, sex, income, and rurality using a nearest neighbor algorithm. Multivariate adjusted logistic regression was used to estimate the odds of CRS based on PM2.5 exposure.Results: Reduced IL‐10 levels were associated with higher PM2.5 exposures in control patients (β = −0.735, p = 0.0196). In exposure‐matched logistic regression analysis, high 12‐month PM2.5 exposure was an independent predictor of CRSwNP (β = 1.97, OR: 7.22, p = 0.0001) after adjustment for age, income, rurality, and comorbid asthma/allergic rhinitis. A similar relationship was not identified for CRSsNP.Conclusions: PM2.5 exposure is associated with reduced IL‐10 in control patients compared to CRS and may increase odds of CRSwNP development.


  • Top Cited Papers
    Open Access

    Effects of inflammatory endotypes on disease trajectory in chronic rhinosinusitis with nasal polyps

    by Christina Dorismond, Yash Trivedi, Mason R. Krysinski, Rory J. Lubner, Li-Ching Huang, Sandeep Goswami, Quanhu Sheng, Rakesh K. Chandra, Naweed I. Chowdhury, Justin H. Turner


  • Open Access

    Nasal Mucus Cytokines Are Correlated with Spirometry Measures in CRS Patients with Comorbid Asthma

    by Rory J. Lubner, Christina Dorismond, Mason Krysinski, Ping Li, Rakesh K. Chandra, Justin H. Turner, Dawn C. Newcomb, Katherine N. Cahill, Naweed I. Chowdhury

    Key points: CRS patients with asthma show differential nasal mucus cytokine signatures based on endotype. IL‐7 concentration is positively associated with higher %FEV1 and %FVC in CRS patients with asthma.

  • Top Cited Papers
    Open Access

    Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves

    by Benjamin Kye Jyn Tan, Ruobing Han, Joseph J Zhao, Nicole Kye Wen Tan, Emrick Sen Hui Quah, Claire Jing-Wen Tan, Yiong Huak Chan, Neville Wei Yang Teo, Tze Choong Charn, Anna See, et al.

    Objective: To clarify in patients with covid-19 the recovery rate of smell and taste, proportion with persistent dysfunction of smell and taste, and prognostic factors associated with recovery of smell and taste. Design: Systematic review and meta-analysis. Data sources: PubMed, Embase, Scopus, Cochrane Library, and medRxiv from inception to 3 October 2021. Review methods: Two blinded reviewers selected observational studies of adults (≥18 years) with covid-19 related dysfunction of smell or taste. Descriptive prognosis studies with time-to-event curves and prognostic association studies of any prognostic factor were included. Data extraction and synthesis: Two reviewers extracted data, evaluated study bias using QUIPS, and appraised evidence quality using GRADE, following PRISMA and MOOSE reporting guidelines. Using iterative numerical algorithms, time-to-event individual patient data (IPD) were reconstructed and pooled to retrieve distribution-free summary survival curves, with recovery rates reported at 30 day intervals for participants who remained alive. To estimate the proportion with persistent smell and taste dysfunction, cure fractions from Weibull non-mixture cure models of plateaued survival curves were logit transformed and pooled in a two stage meta-analysis. Conventional aggregate data meta-analysis was performed to explore unadjusted associations of prognostic factors with recovery. Main outcome measures: The primary outcomes were the proportions of patients remaining with smell or taste dysfunction. Secondary outcomes were the odds ratios of prognostic variables associated with recovery of smell and taste. Results: 18 studies (3699 patients) from 4180 records were included in reconstructed IPD meta-analyses. Risk of bias was low to moderate; conclusions remained unaltered after exclusion of four high risk studies. Evidence quality was moderate to high. Based on parametric cure modelling, persistent self-reported smell and taste dysfunction could develop in an estimated 5.6% (95% confidence interval 2.7% to 11.0%, I 2 =70%, τ 2 =0.756, 95% prediction interval 0.7% to 33.5%) and 4.4% (1.2% to 14.6%, I 2 =67%, τ 2 =0.684, 95% prediction interval 0.0% to 49.0%) of patients, respectively. Sensitivity analyses suggest these could be underestimates. At 30, 60, 90, and 180 days, respectively, 74.1% (95% confidence interval 64.0% to 81.3%), 85.8% (77.6% to 90.9%), 90.0% (83.3% to 94.0%), and 95.7% (89.5% to 98.3%) of patients recovered their sense of smell (I 2 =0.0-77.2%, τ 2 =0.006-0.050) and 78.8% (70.5% to 84.7%), 87.7% (82.0% to 91.6%), 90.3% (83.5% to 94.3%), and 98.0% (92.2% to 95.5%) recovered their sense of taste (range of I 2 =0.0-72.1%, τ 2 =0.000-0.015). Women were less likely to recover their sense of smell (odds ratio 0.52, 95% confidence interval 0.37 to 0.72, seven studies, I 2 =20%, τ 2 =0.0224) and taste (0.31, 0.13 to 0.72, seven studies, I 2 =78%, τ 2 =0.5121) than men, and patients with greater initial severity of dysfunction (0.48, 0.31 to 0.73, five studies, I 2 =10%, τ 2 2 =0%, τ 2 <0.001) were less likely to recover their sense of smell. Conclusions: A substantial proportion of patients with covid-19 might develop long lasting change in their sense of smell or taste. This could contribute to the growing burden of long covid. Systematic review registration: PROSPERO CRD42021283922.


  • Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis

    by Nikita Chapurin, Douglas J. Totten, Justin C. Morse, Mohammad S. Khurram, Peter C. Louis, Robert J. Sinard, Naweed I. Chowdhury

    Background: Sinonasal teratocarcinosarcoma (SNTCS) is a rare malignancy of the anterior skull base with only 127 cases described in the English literature. Given the rarity of this tumor, new cases and analysis of published reports may assist in future management of SNTCS. Objectives: 1) Describe findings from a systematic review of all available literature for malignant SNTCS including the clinical presentation, treatment modalities and outcomes. 2) Present two new cases of this rare anterior skull base tumor. 3) Compare treatment outcomes with respect to recurrence and mortality. Methods: A systematic review of all English literature available in 2 comprehensive databases was conducted by two independent reviewers using PRISMA guidelines. 85 publications were identified. Each case was reviewed for demographics, treatment and survival, and aggregate treatment outcomes were compared using Kaplan-Meier analysis. Results: A total of 64 articles meeting inclusion criteria were reported in the literature between 1977-2018. This represented a total of 127 patients, with a strong male predominance (83%) and mean age of 50 years (range 10–82). Mean follow-up was 21 months. Recurrence rate was 38%, with mean survival at 2 years of 55%. Almost all patients underwent surgery as a primary treatment modality (90%). The majority of cases were treated with multimodal therapy, with 55% receiving surgery and radiation and 20% receiving surgery with adjuvant chemoradiation. Kaplan-Meier analysis demonstrated a significant survival advantage for patients treated with combined therapy compared to surgery alone (p < 0.001) but did not show differences in recurrence (p = 0.085). Conclusion: Two-year survival rates for SNTCS are 55%. Multimodality treatment outcomes appear to be superior to surgery alone based on the published data of this rare skull base tumor, although heterogeneity of treatment methods and reporting bias limits the generalizability of these findings.


  • Elevated mucus interleukin‐17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis

    by Nikita Chapurin, Ping Li, Rakesh K. Chandra, Justin H. Turner, Naweed I. Chowdhury

    Background: Recent advances in molecular biology have enabled the identification of potential inflammatory endotypes of chronic rhinosinusitis (CRS), with prior work suggesting differential short‐term surgical outcome trajectories based on cytokine signatures. However, there is a paucity of data assessing long‐term treatment failure and need for revision surgery based on inflammatory biomarkers.Methods: Retrospective analysis of prospectively collected cross‐sectional data from 231 patients electing surgical therapy for CRS. Intraoperative mucus specimens were quantitatively sampled for inflammatory cytokines using a multiplex flow cytometric bead assay. Univariate Spearman correlations between cytokine levels and prior number of surgeries were assessed. A stepwise adjusted multivariate Poisson regression analysis was used to model patient‐reported prior sinus surgery counts as a function of cytokine levels.Results: Several cytokines (interleukin [IL]‐1β, IL‐4, IL‐5, IL‐6, IL‐8, IL‐10, IL‐13, IL‐17A, tumor necrosis factor α [TNF‐α], interferon γ [IFN‐γ], and eotaxin) demonstrated significant positive correlations with number of prior surgeries. However, only higher IL‐17A levels were independently associated with a higher number of prior sinus surgeries (β = 0.345, p = 0.0003) after adjusting for the significant covariates of age (β = 0.018, p = 0.0036), Lund‐Mackay score (β = –0.046, p = 0.02), history of aspirin‐exacerbated respiratory disease (β = 1.01, p < 0.0001) and allergic fungal rhinosinusitis (β = 1.08, p < 0.0001). Higher levels of regulated on activation, normal T‐cell expressed and secreted (RANTES) were conversely associated with a lower number of prior surgeries (β = –0.17, p = 0.048).Conclusion: An IL‐17A–predominant cytokine profile is linked to an increased number of prior sinus surgeries. Thus, type 3 inflammatory markers may indicate a particularly difficult‐to‐treat, recalcitrant CRS endotype.